Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
227.3 USD | +5.11% |
|
+12.61% | -3.85% |
07-16 | Stephens Adjusts Price Target on Charles River Laboratories International to $250 From $280 | MT |
07-10 | Baird Adjusts Price Target on Charles River Laboratories International to $239 From $271 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.85% | 11.14B | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- Transcript : Charles River Laboratories International, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 07